Hillsdale Investment Management Inc. Organogenesis Holdings Inc. Transaction History

Hillsdale Investment Management Inc.

  • $1.13 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 21, 2021
SELL
$13.71 - $17.18 $841,794 - $1.05 Million
-61,400 Closed
0 $0
Q2 2021

Jul 29, 2021
SELL
$14.92 - $23.23 $74,600 - $116,150
-5,000 Reduced 7.53%
61,400 $1.02 Million
Q1 2021

Apr 22, 2021
BUY
$7.33 - $21.06 $486,712 - $1.4 Million
66,400 New
66,400 $1.21 Million

Others Institutions Holding ORGO

# of Institutions
120
Shares Held
62.3M
Call Options Held
28.8K
Put Options Held
27.9K
View Full List

About Organogenesis Holdings Inc.

ORGO Quotes by TradingView
  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $374M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Hillsdale Investment Management Inc. Portfolio

Follow Hillsdale Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hillsdale Investment Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email